Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology
Authors:
Open Access
- 24 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 175 (1) , 41-48
Abstract
Summary: In various autoimmune diseases, anti-tumour necrosis factor (TNF)-α treatment has been shown to reduce both clinical disease severity and T helper type 1 (Th1)1/Th17 responses. In experimental autoimmune encephalomyelitis (EAE), however, the role of TNF-α has remained unclear. Here, C57BL/6 mice were immunized with myelin oligodendrocyte glycoprotein (MOG) peptide 35–55 and treated with anti-TNF-α, control antibody or vehicle. The clinical disease course, incidence and severity were assessed. On day 20 after immunization the antigen-specific Th1/Th17 response was evaluated by enzyme-linked immunospot (ELISPOT) in spleen and central nervous system (CNS). Also, the extent of spinal cord histopathology was analysed on semi- and ultrathin sections. Our results demonstrate that anti-TNF-α treatment reduced the incidence and delayed the onset of EAE, but had no effect on disease severity once EAE had been established. Whereas anti-TNF-α treatment induced an increase in splenic Th1/Th17 responses, there was no effect on the number of antigen-specific Th1/Th17 cells in the spinal cord. Accordingly, the degree of CNS histopathology was comparable in control and anti-TNF-α-treated mice. In conclusion, while the anti-TNF-α treatment had neither immunosuppressive effects on the Th1/Th17 response in the CNS nor histoprotective properties in EAE, it enhanced the myelin-specific T cell response in the immune periphery.Keywords
Funding Information
- German Research Foundation
- Köln Fortune Programm
- Imhoff-Stiftung
This publication has 32 references indexed in Scilit:
- Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid CellsThe Journal of Immunology, 2011
- Death receptor signalling in central nervous system inflammation and demyelinationTrends in Neurosciences, 2011
- Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitisImmunology, 2011
- Contrasting effects of TNF and anti‐TNF on the activation of effector T cells and regulatory T cells in autoimmunityFEBS Letters, 2011
- Animal models of multiple sclerosis—Potentials and limitationsProgress in Neurobiology, 2010
- Lack of TNFR p55 Results in Heightened Expression of IFN-γ and IL-17 during the Development of Reactive ArthritisThe Journal of Immunology, 2010
- Acquisition of regulatory function by human CD8+ T cells treated with anti‐CD3 antibody requires TNFEuropean Journal of Immunology, 2010
- A protective function for interleukin 17A in T cell–mediated intestinal inflammationNature Immunology, 2009
- Naive Human T-Cells become Non-Responsive towards Anti-TNFα (Infliximab) Treatment In vitro if Co-Stimulated through CD28Scandinavian Journal of Immunology, 2008
- Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cellsJournal of Experimental Medicine, 2008